According to the analysis of Transparency Market Research (TMR), the
global HCS software and services market is predicted to reach a
revenue valuation of approximately US$1.1 bn by the end of 2022,
progressing from a valuation of around US$0.8 bn achieved in 2017.
During the forecast period 2017–2022, the market could rise at a
6.9% CAGR.
The sales of HCS instruments are prognosticated to be boosted with
the towering demand for novel cell analysis technologies due to
enlarging drug discovery processes and improved toxicity studies. The
demand in the world HCS software and services market could be
increased by the development of solutions offering significant
sensitivity in determining problems as serious as hepatotoxicity.
This could be on account of the rising significance of the risk
assessment of severe diseases for drug discovery across a range of
biotechnology and pharmaceutical companies.
Although the high cost of HCS instruments could negatively impact
growth, their growing demand for providing comprehensive offerings to
lab services is foreseen to help the world HCS software and services
market achieve a healthy comeback.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=30920
The world HCS software and services market is projected to be
segregated as per product type classification into two segments, i.e.
HCS services and HCS software. According to the publication, the HCS
services market could exhibit dominance with its superior valuation
of close to a US$0.8 bn anticipated to be attained by 2022. The
market could also be dependent on industry segments such as bio,
educational institutions, government organizations, independent
contract research organizations (CROs), and pharmaceutical and
healthcare. As per application, the market is forecasted to be
categorized into toxicity studies, target identification and
validation, primary and secondary screening, and compound profiling.
By region, players operating in the world HCS software and services
market could find opportunities prevailing in North America, the
Middle East and Africa (MEA), Latin America, Europe, and Asia Pacific
except Japan (APEJ) and Japan. With a 7.5% CAGR prophesied to be
posted during the course of the forecast period, North America is
envisaged to register a dominating share in the market on the basis
of revenue.
Request a Brochure of the Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30920
The global high content screening (HCS) software and services market
is foretold to welcome a bolstering demand owing to the augmented
prominence of the secondary screening of cells for toxicity studies.
Research and educational institutions could help the market gain a
strong traction in the coming years. HCS instrument manufacturers are
expected to receive a wealth of opportunities created with the
establishment of automated systems for cell scalability and
separation analysis. Furthermore, the fortifying growth of the HCS
technology in view of the soaring demand for vastly efficient
therapeutic cell purification protocols could augur well for the
market.
Among the leading companies, Thermo Fisher Scientific, Inc., General
Electric Company, Becton, Dickinson & Company, PerkinElmer, Inc.,
Yokogawa Electric Corporation, Olympus Corporation, Merck & Co.,
Inc., Thorlabs, Inc., Sysmex Corporation, and Danaher Corporation are
envisioned to showcase their prominence in the worldwide HCS software
and services market.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=30920
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment